Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Bayer Inc
Scientific Title
A Phase III, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Copanlisib in Combination With Rituximab in Patients With Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)